News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ReVision Optics, Inc. Appoints Internationally Recognized Ophthalmologist Dr. Stephen G. Slade to its Board of Directors


4/23/2012 11:53:29 AM

LAKE FOREST, Calif.--(BUSINESS WIRE)--ReVision Optics®, Inc. (RVO), a leader in implantable microlens technology to treat presbyopia, today announced the appointment of the esteemed vision correction expert Stephen Slade, M.D., FACS, to the Company’s Board of Directors. “Dr. Slade is a major force in the field of ophthalmology and a renowned expert in treating patients who require vision correction such as presbyopia. We are delighted to have him join our Board and look forward to his contributions,” said J. Randy Alexander, Chairman of the Board of ReVision Optics. “Dr. Slade has pioneered many of the latest technologies for vision correction in use today. Eye surgery patients from around the world seek his professional services and, remarkably, more than 450 of his fellow eye surgeons have chosen him to perform surgery on them. Dr. Slade brings to ReVision Optics a wealth of knowledge, regulatory expertise and industry contacts that will be highly beneficial as we pursue FDA approval to market our PresbyLens® microlens.”

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES